Patents
Patents for C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
08/2009
08/05/2009EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection
08/04/2009US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate
07/2009
07/29/2009EP2081891A2 Pharmaceutical compounds having hsp90 inhibitory or modulating activity
07/29/2009EP1601671B1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament
07/28/2009US7566732 5-(1H-benzimidazol-2-ylmethylene)-3-(4-fluorophenyl)-2-thioxo-1,3-thiazolidin-4-one; ubiquitin ligase (synthetase) inhibitors; inhibit ubiquitination of target proteins; poxviruses; herpesviruses; retroviruses; variola viruses; smallpox; hemorrhagic smallpox; HIV; vaccines; side effect reduction
07/23/2009WO2009013348A3 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
07/21/2009US7563794 Ziprasidone free from colored impurities and a process for its preparation
07/16/2009US20090181970 Functionalized diarylisoxazoles inhibitors of ciclooxygenase
07/14/2009US7560462 Compounds useful for inhibiting CHK1
07/14/2009US7560456 Pesticidal pyridinecarboxamide derivatives
07/08/2009CN100509797C Thiophene derivatives used as antiviral agent against flavivirus infections
07/01/2009EP2073807A1 Pharmaceutical combinations
06/2009
06/25/2009WO2009078498A1 Biarylpyrazole 4-carboxamides as cannabinoid cb1 receptor ligands
06/24/2009CN100503576C Substituted azole compounds, preparation and application thereof
06/16/2009US7547782 Met kinase inhibitors
06/10/2009EP1805142A4 Novel pyridine compounds, process for their preparation and compositions containing them
06/02/2009US7541368 Pyrazoles as inhibitors of tumor necrosis factor
05/2009
05/28/2009US20090137806 Dual nk1/nk3 receptor antagonists
05/22/2009WO2009046010A3 Monomethine dyes
05/21/2009US20090131403 Nitrogenated heterocyclic derivative , and pharmaceutical agent comprising the derivative as active ingredient
05/19/2009US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
05/19/2009US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
05/12/2009US7531542 Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
05/12/2009CA2428604C Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives
05/06/2009EP2054411A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
05/06/2009CN101426769A Five-membered heterocyclic invertebrate pest control agents
05/05/2009US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents
04/2009
04/29/2009EP1542994B1 Novel oxazole compounds as transforming growth factor (tgf) inhibitor
04/28/2009US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders
04/23/2009US20090105214 Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
04/14/2009US7517994 Heterocyclic inhibitors of MEK and methods of use thereof
04/09/2009WO2009046010A2 Monomethine dyes
03/2009
03/18/2009EP2035372A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
03/18/2009EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
03/10/2009US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity
03/10/2009US7501416 Quinoxaline compounds and methods of using them
03/05/2009WO2009027393A2 Pyrazole compounds for controlling invertebrate pests
03/05/2009US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
03/05/2009CA2695733A1 Pyrazole compounds for controlling invertebrate pests
03/04/2009EP2029546A1 Aryl-substituted heterocycles, and use thereof
02/2009
02/24/2009US7494998 Benzisoxazole piperazine compounds and methods of use thereof
02/17/2009US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use
02/12/2009WO2009020579A1 Gamma secretase modulators
02/12/2009CA2695864A1 Gamma secretase modulators
02/05/2009WO2009015776A1 Substituted aryloxazoles and the use thereof
01/2009
01/29/2009WO2009013348A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
01/29/2009CA2694275A1 Organic compounds
01/28/2009EP2018545A2 Biradical polarizing agents for dynamic nuclear polarization
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/21/2009EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives
01/13/2009US7476663 Substituted thiophene carboxamides
01/08/2009WO2008127275A3 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
12/2008
12/30/2008CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/10/2008CN101321749A Novel vinylogous acids derivatives
12/02/2008US7459454 Aminopyrazine derivatives and compositions
11/2008
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/26/2008EP1995246A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
11/25/2008US7456192 3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
11/13/2008WO2008048714A3 Biradical polarizing agents for dynamic nuclear polarization
11/13/2008US20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers
11/12/2008CN101304996A Pyrimidine derivatives for the inhibition of IGF-1R tyrosine kinase activity
11/05/2008EP1987013A1 Bicyclic sphingosine 1-phosphate analogs
11/04/2008US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract
10/2008
10/29/2008CN101296927A Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
10/23/2008WO2008127275A2 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
10/23/2008WO2008064218A3 Amido anti-viral compounds
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/16/2008WO2008124075A1 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008US20080255205 protein kinase receptors (like Tie-2 and Aurora) modulators; to treat cancer, inflammation and related disorders; to regulate active angiogenesis, cell-signal transduction; 5-(3-(1H-tetrazol-5-yl)pyridin-2-yloxy)-N-(3-chlorobenzyl)-2-fluorobenzamide
10/16/2008CA2681861A1 Ornithine derivative
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/02/2008WO2008116881A1 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
10/02/2008CA2682012A1 Substituted pyrrolidinamides, manufacturing and use thereof as medicaments
10/01/2008EP1975165A1 Substituted pyrrolidinamides, their production and utilisation as medicine
10/01/2008CN101277953A Atives of 2-aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals
09/2008
09/30/2008US7429607 5-HT2B receptor antagonists
09/30/2008US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents
09/30/2008US7429593 Utilities of amide compounds
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/24/2008EP1971594A2 Substituted pyrazalones
09/23/2008US7427620 4-{4-[4-{4-[2-(2-pyridinyl)-2-(1 H-1,2,4-triazol- 1 -yl-methyl)- 1 ,3-dioxolan-4-yl-methoxy]phenyl}- 1-piperazinyl]-phenyl}-2-( 1-methyl)-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one; better toxicological profile and of reduced interaction with other drugs; good solubility in water, bioavailability
09/16/2008CA2427221C Process and intermediates for preparing anti-cancer compounds
09/11/2008US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates
09/10/2008EP1965640A2 Thienylpyridyl carboxamides
09/09/2008US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
09/09/2008CA2252163C D-proline derivatives
09/04/2008US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction
09/04/2008US20080214526 Macrocyclic Compounds and Compositions Useful as Bace Inhibitors
09/02/2008US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes
08/2008
08/20/2008EP1957483A1 Novel vinylogous acids derivatives
08/13/2008EP1954138A2 Insecticidal methods using 3-amino-1,2-benzisothiazole derivatives
08/12/2008US7410972 Compounds
08/12/2008US7410961 2,6-disubstituted piperiddines as modulators
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/05/2008US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
08/05/2008US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15